Literature DB >> 18837429

Rhabdomyosarcoma masquerading as acute leukemia.

Yuichi Shinkoda1, Yoshihisa Nagatoshi, Reiji Fukano, Kenichi Nishiyama, Jun Okamura.   

Abstract

Rhabdomyosarcoma (RMS) masquerading as acute leukemia (AL) is very rare. We describe three cases with RMS without any symptoms of solid tumors. Bone marrow (BM) showed approximately 95% of blast-like abnormal cells, lacking almost all of the surface antigens of myeloid- and lymphoid-lineage. The immunohistochemistry revealed positive of the cells for actin, desmin and myoglobin. It is important to examine BM samples by immunohistochemistry, when a flow cytometric analysis reveals an unusual presentation. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh：

Year:  2009        PMID： 18837429     DOI： 10.1002/pbc.21783

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  8 in total

1.  Muscling in: Uncovering the origins of rhabdomyosarcoma.

Authors:  Simone Hettmer; Amy J Wagers
Journal:  Nat Med       Date:  2010-02       Impact factor: 53.440

Review 2.  Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.

Authors:  Venkatesh P Kashi; Mark E Hatley; Rene L Galindo
Journal:  Nat Rev Cancer       Date:  2015-07       Impact factor: 60.716

3.  Severe Tumor Lysis Syndrome and Acute Pulmonary Edema Requiring Extracorporeal Membrane Oxygenation Following Initiation of Chemotherapy for Metastatic Alveolar Rhabdomyosarcoma.

Authors:  Ethan Sanford; Traci Wolbrink; Jennifer Mack; R Grant Rowe
Journal:  Pediatr Blood Cancer       Date:  2015-12-29       Impact factor: 3.167

4.  A leukemic presentation of alveolar rhabdomyosarcoma in a 52-year-old woman without an identifiable primary tumor.

Authors:  Jason B Kern; Anselm Hii; Matthew J Kruse; Zsolt Szabo; Pedram Argani; Michele K Hibbard; Douglas E Gladstone; Christian Meyer; Rui Zheng; Michael J Borowitz; Amy S Duffield
Journal:  Int J Surg Pathol       Date:  2014-10-10       Impact factor: 1.271

5.  Complete mimicry: a case of alveolar rhabdomyosarcoma masquerading as acute leukemia.

Authors:  Osamu Imataki; Makiko Uemura; Shumpei Uchida; Shigeyuki Yokokura; Akihiro Takeuchi; Ryo Ishikawa; Akihiro Kondo; Kayoko Seo; Norimitsu Kadowaki
Journal:  Diagn Pathol       Date:  2017-11-02       Impact factor: 2.644

6.  Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma.

Authors:  Suying Lu; Chengtao Sun; Huimou Chen; Chao Zhang; Wei Li; Liuhong Wu; Jia Zhu; Feifei Sun; Junting Huang; Juan Wang; Zijun Zhen; Ruiqing Cai; Xiaofei Sun; Yizhuo Zhang; Xing Zhang
Journal:  Cancer Manag Res       Date:  2020-11-26       Impact factor: 3.989

7.  Rhabdomyosarcoma With Diffuse Bone Marrow Metastases.

Authors:  Daniel Huang; Pankaj Watal; Dennis Drehner; Deeksha Dhar; Tushar Chandra
Journal:  Cureus       Date:  2022-02-03

8.  Acute Myeloid Leukemia with RAM Immunophenotype: A Pediatric Case with Unusual Morphologic Features.

Authors:  Miriam Conces; Rolla Abu-Arja; Suzanne Reed; Hemalatha G Rangarajan; Terri L Guinipero; Michael R Loken; Lisa Eidenschink Brodersen; Samir B Kahwash
Journal:  Hematol Rep       Date:  2017-06-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.